TCF7L2 is a transcription factor gene strongly associated with type 2 diabetes risk. Menopause (Wechseljahre) involves hormonal changes that can reduce insulin sensitivity and increase diabetes risk. The connection between TCF7L2 and menopause is therefore indirect: women carrying risk variants in TCF7L2 may face an elevated diabetes risk during menopause. However, robust studies directly examining the interaction between TCF7L2 and menopausal hormones are lacking. The evidence for the TCF7L2-diabetes association comes from large GWAS and is well-established, but effect sizes are modest. In practice, a DNA test for TCF7L2 can provide risk information, but it should not be overinterpreted. Lifestyle, diet, and medical monitoring are more impactful. The direct link to menopause is not well-supported by current evidence.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-cc9fade95a43c99c420e9eab